Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1

Conditions

Primary Myelofibrosis 41Myeloproliferative Disorders 30Polycythemia Vera 28Myelodysplastic Syndromes 15Leukemia, Myeloid, Acute 13Thrombocythemia, Essential 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Neoplasms 7Myelodysplastic-Myeloproliferative Diseases 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia 6Hematologic Diseases 5Thrombocytosis 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Bone Marrow Diseases 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Monocytic, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Graft vs Host Disease 2Breast Neoplasms 2Blast Crisis 2Anemia 2

Interventions

nilotinib 3asciminib 3Imatinib Mesylate 3bosutinib 2Dasatinib 2ruxolitinib 1ponatinib 1milatuzumab 1lonafarnib 1Vision, Ocular 1Panobinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bronchiolitis Obliterans Syndrome × ruxolitinib × Myeloid × Clear all
NCT02386800 2026-05-27

CINC424A2X01B Rollover Protocol

Novartis

Phase 4 Active not recruiting
279 enrolled
MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Polycythemia Vera, Thalassemia, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡